Featured Research

from universities, journals, and other organizations

Standard approaches to menopause symptoms discount non-Western experiences

Date:
May 30, 2014
Source:
University of Bristol
Summary:
Understanding menopausal symptoms through a simple checklist has serious limitations, particularly within different ethnic groups or populations, according to a new study of British Pakistani women's beliefs about and experiences of menopause. The research concludes that the symptom experience of non-Western groups has not had the opportunity to inform theoretical developments around menopause symptoms in the same way that the experience of Western groups has.

Dr Mwenza T. Blell of the University of Bristol interviewed 257 British Pakistani women aged 39-61 living in West Yorkshire and found that the standard checklist approach to studying menopause symptoms, which ignores women's understanding of their own experience, leaves researchers and clinicians with gaps in their knowledge of the 'true' symptoms of menopause.

Many previous studies into the menopause have relied on standardised checklists, such as the Blatt-Kupperman index and the Menopause Symptom Checklist, that were derived from the clinical experiences of women living in New York and Chicago in the mid-twentieth century and so focus on a distinctly Western bio-medical model of menopause.

Dr Blell's study explored the potential of using an alternative approach to better identify women's beliefs about the experiences attributable to menopause. Information was gathered through interviews and in informal settings in order to gain a more rounded understanding of the variety of beliefs within the British Pakistani community. The findings suggest a considerable discrepancy between women's understanding of menopausal symptoms and the assumptions made by previous research.

Dr Blell said: "The standardised checklists claim to tell the whole story of what menopause is when really we haven't let everyone be part of the conversation. By adopting a more open-ended approach, instead of the standard checklist mode, useful data can be captured that specifically reflects varied beliefs and understandings of the experience of the menopause."

For example, the use of a more open-ended approach highlighted that many of the study participants mentioned an increase in the size of the abdomen -- which many standard checklists consider to be unrelated to menopause -- as one of their symptoms.

This is an important finding as it suggests other populations may have a different understanding about the relationship between changes in body fat patterning and menopause that has not been fully explored in Western medicine due to the established assumptions surrounding the experience of menopause.

Dr Blell said: "The amazing thing is that this finding has come up before in other studies of women of South Asian origin and has just been swept under the carpet, assumed to be a mistaken belief women need to be educated out of, when that really isn't the case."

The research concludes that the symptom experience of non-Western groups has not had the opportunity to inform theoretical developments around menopause symptoms in the same way that the experience of Western groups has.

The understanding of other groups may indicate new directions for research such as the identification of change in body fat distribution, which seems to apply cross-culturally, and its relationship with the local understanding of menopause and its population-specific chronic disease risk.


Story Source:

The above story is based on materials provided by University of Bristol. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mwenza T. Blell. Menopausal symptoms among British Pakistani women. Menopause, 2014; 1 DOI: 10.1097/GME.0000000000000256

Cite This Page:

University of Bristol. "Standard approaches to menopause symptoms discount non-Western experiences." ScienceDaily. ScienceDaily, 30 May 2014. <www.sciencedaily.com/releases/2014/05/140530124321.htm>.
University of Bristol. (2014, May 30). Standard approaches to menopause symptoms discount non-Western experiences. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/05/140530124321.htm
University of Bristol. "Standard approaches to menopause symptoms discount non-Western experiences." ScienceDaily. www.sciencedaily.com/releases/2014/05/140530124321.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins